Fig. 3From: High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancerThe relative change of serum 25-hydroxyvitamin D level over the neoadjuvant course for individual study subjects. Each patient is represented by a line and assigned a group according to the season of diagnosis. Abbreviation: Post-Rx completion of neoadjuvant therapyBack to article page